These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21393964)

  • 1. Acute graft versus host disease.
    Kumawat MK; Khandpur S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):217-9. PubMed ID: 21393964
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late onset of acute graft-versus-host disease.
    Dulley FL; Shulman HM; Massumoto CM; Loterio HA; Dorlhiac-Llacer PE; Beitler B; Velloso RP; D'Amico EA; Garicochea B; Martinez GA
    Clin Transpl; 1989; ():312. PubMed ID: 2487588
    [No Abstract]   [Full Text] [Related]  

  • 4. Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
    Baron F; Frère P; Baudoux E; Schaaf-Lafontaine N; Fillet G; Beguin Y
    Haematologica; 2003 Jul; 88(7):835-7. PubMed ID: 12857568
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease.
    Cutting R; Wright J; Underwood J
    Bone Marrow Transplant; 2006 Jul; 38(1):77-8. PubMed ID: 16715105
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
    Neumann S; Schoppmeyer K; Lange T; Wiedmann M; Golsong J; Tannapfel A; Mossner J; Niederwieser D; Caca K
    Gastrointest Endosc; 2007 Mar; 65(3):403-9. PubMed ID: 17321239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute graft-versus-host disease (aGVHD) presenting with an acquired lupus anticoagulant.
    Kharfan-Dabaja MA; Morgensztern D; Santos E; Goodman M; Fernandez HF
    Bone Marrow Transplant; 2003 Jan; 31(2):129-31. PubMed ID: 12621495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
    Huang XJ; Chen YH; Xu LP; Zhang YC; Liu DH; Guo NL; Lu DP
    Chin Med J (Engl); 2004 Apr; 117(4):604-7. PubMed ID: 15109458
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic blood stem cell transplantation in advanced chronic myeloid leukemia--high response rate associated with increased chronic graft-versus-host disease.
    Sayer HG; Kasper C; Mügge LO; Schilling K; Scholl S; Höffken K
    Haematologica; 2003 Jul; 88(7):831-3. PubMed ID: 12857566
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
    Chun C; Fang JP; Xue HM; Zhou DH; Huang K; Xu HG; Huang SL
    Transfus Apher Sci; 2011 Feb; 44(1):41-7. PubMed ID: 21256085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant.
    Silva F; Pérez-Simón JA; Caballero Velazquez T; Encinas C; Sánchez-Guijo FM; Díez-Campelo M; Colado E; Martín J; Villanueva-Gomez F; Vazquez L; Del Cañizo C; Caballero D; San Miguel J
    Am J Hematol; 2010 Apr; 85(4):290-3. PubMed ID: 20162543
    [No Abstract]   [Full Text] [Related]  

  • 18. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation.
    Ju XP; Xu B; Xiao ZP; Li JY; Chen L; Lu SQ; Huang ZX
    Bone Marrow Transplant; 2005 Jun; 35(12):1179-86. PubMed ID: 15852028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Transplantation in Aplastic Anaemia.
    Nair V; Apte S
    J Assoc Physicians India; 2015 Mar; 63(3 Suppl):21-5. PubMed ID: 26529863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.